$385 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 20 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 13.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXK | Sell | ACCELERATE DIAGNOSTICS INC | $72,392,000 | -40.3% | 5,037,747 | -10.7% | 18.82% | -10.4% |
| QDEL | Sell | QUIDEL CORP | $44,420,000 | -25.1% | 2,573,554 | -8.0% | 11.55% | +12.4% |
| OPK | Buy | OPKO HEALTH INC | $40,666,000 | +3.4% | 3,914,000 | +0.0% | 10.57% | +55.2% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $40,393,000 | -44.0% | 2,694,636 | -18.1% | 10.50% | -15.9% |
| MZOR | Buy | MAZOR ROBOTICS LTDsponsored ads | $36,195,000 | +26.5% | 2,909,566 | +3.3% | 9.41% | +89.8% |
| TSRO | Buy | TESARO INC | $28,222,000 | -0.3% | 640,966 | +18.5% | 7.34% | +49.6% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $26,610,000 | -44.6% | 3,312,089 | -9.4% | 6.92% | -16.8% |
| ARAY | Sell | ACCURAY INC | $14,758,000 | -24.2% | 2,553,218 | -11.5% | 3.84% | +13.8% |
| BIOL | BIOLASE INC | $13,794,000 | +55.8% | 10,529,525 | 0.0% | 3.59% | +133.8% | |
| XON | Sell | INTREXON CORP | $13,682,000 | -51.3% | 403,729 | -56.7% | 3.56% | -27.0% |
| VRML | VERMILLION INC | $12,678,000 | -18.3% | 8,624,225 | 0.0% | 3.30% | +22.6% | |
| HNSN | Hansen Medical | $11,702,000 | +11.8% | 4,491,820 | 0.0% | 3.04% | +67.8% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $8,903,000 | -29.1% | 5,818,805 | -12.4% | 2.32% | +6.4% |
| AGEN | Sell | AGENUS INC | $7,831,000 | -39.8% | 1,882,477 | -34.3% | 2.04% | -9.7% |
| TTHI | Sell | TRANSITION THERAPEUTICS INC | $4,887,000 | -34.9% | 3,817,972 | -2.3% | 1.27% | -2.2% |
| CFRX | CONTRAFECT CORP | $4,019,000 | -28.4% | 1,182,032 | 0.0% | 1.04% | +7.4% | |
| BIIB | Sell | BIOGEN INC | $1,750,000 | -26.0% | 6,723 | -12.9% | 0.46% | +11.0% |
| MBLX | Sell | METABOLIX Inc | $1,381,000 | -4.0% | 726,935 | -22.1% | 0.36% | +44.2% |
| EYES | Sell | SECOND SIGHT MED PRODS INC | $245,000 | -79.5% | 50,804 | -75.0% | 0.06% | -69.2% |
| ZIOP | Sell | ZIOPHARM ONCOLOGY INC | $49,000 | -95.5% | 6,661 | -94.9% | 0.01% | -93.1% |
| CMRX | Exit | CHIMERIX INC | $0 | – | -736,421 | -100.0% | -1.14% | – |
| WBMD | Exit | WEBMD HEALTH CORP | $0 | – | -238,103 | -100.0% | -1.99% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -815,838 | -100.0% | -6.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.